Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
28.00
1.31 (4.91%)
At close: Aug 15, 2025, 3:59 PM
28.20
0.70%
Pre-market: Aug 18, 2025, 08:31 AM EDT
Moderna Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -825M | -971M | -1.12B | 13M | -1.28B | -1.18B | 217M | -3.63B | -1.38B | 79M | 1.47B | 1.04B | 2.2B | 3.66B | 4.87B | 3.33B | 2.78B | 1.22B |
Depreciation & Amortization | 57M | 39M | 60M | 52M | 41M | 36M | 202M | 249M | 92M | 78M | 80M | 113M | 76M | 79M | 78M | 70M | 69M | 15M |
Stock-Based Compensation | 130M | 115M | 104M | 112M | 112M | 101M | 79M | 77M | 74M | 75M | 62M | 70M | 50M | 44M | 37M | 40M | 35M | 30M |
Other Working Capital | -166M | -327M | 206M | 1.4B | -120M | -299M | -1.03B | 1.41B | -255M | -1.51B | -2.44B | -889M | -2.3B | -354M | -1.13B | 1.29B | 92M | 4.03B |
Other Non-Cash Items | 16M | -9M | 44M | -1.83B | -2M | -11M | -19M | 58M | -55M | -3M | -12M | 27M | 26M | 18M | 21M | 3M | 8M | 5M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -106M | 1.46B | -220M | -310M | -86M | -97M | -230M | -146M | -229M | n/a | -22M | -50M |
Change in Working Capital | -297M | -211M | 1.74B | 86M | -146M | 60M | 249M | 182M | 574M | -1.14B | 153M | -904M | -1.81B | -889M | -1.47B | -170M | 1.19B | 1.75B |
Operating Cash Flow | -919M | -1.04B | 825M | -1.57B | -1.27B | -989M | 622M | -1.6B | -915M | -1.23B | 1.66B | 252M | 304M | 2.76B | 3.31B | 3.28B | 4.06B | 2.97B |
Capital Expenditures | -3M | -127M | -522M | -151M | -182M | -196M | -220M | -140M | -234M | -113M | -92M | -89M | -87M | -132M | -120M | -99M | -30M | -35M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.29B | -1.76B | -1.89B | -1.25B | -846M | -2.54B | -1.66B | -816M | -196M | -1.11B | -2.51B | -191M | -3.16B | -5.57B | -2.37B | -3.72B | -5.83B | -726M |
Sales Maturities Of Investments | 1.86B | 2.62B | 1.87B | 2.12B | 2.68B | 2.86B | 1.34B | 1.75B | 2.37B | 3.32B | 1.56B | 1.23B | 2.1B | 1.82B | 1.39B | 492M | 1.99B | 581M |
Other Investing Acitivies | n/a | -10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5M | n/a | n/a | -35M | -30M | n/a | n/a | n/a |
Investing Cash Flow | 564M | 730M | -539M | 721M | 1.65B | 118M | -538M | 789M | 1.94B | 2.01B | -1.05B | 945M | -1.15B | -3.92B | -1.14B | -3.33B | -3.88B | -180M |
Debt Repayment | -5M | 2M | -14M | 3M | 2M | -1M | -124M | -65M | -56M | -25M | -61M | -46M | -46M | -31M | -44M | -34M | -60M | -2M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | -628M | -526M | -402M | -1.01B | -1.3B | -623M | -857M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -1M | n/a | n/a | n/a | n/a | n/a | n/a | 16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9M | 4M | -3M | 11M | 34M | 14M | -109M | -58M | -668M | -542M | -438M | -1.04B | -1.33B | -642M | -873M | -2M | -24M | 26M |
Net Cash Flow | -345M | -303M | 282M | -833M | 409M | -857M | -25M | -869M | 361M | 244M | 176M | 156M | -2.17B | -1.8B | 1.3B | -53M | 161M | 2.82B |
Free Cash Flow | -922M | -1.16B | 303M | -1.72B | -1.46B | -1.19B | 402M | -1.74B | -1.15B | -1.34B | 1.57B | 163M | 217M | 2.63B | 3.19B | 3.18B | 4.03B | 2.94B |